Cara Therapeutics, Inc.
Q4 2024 13F Holders
Symbol
CARA
CUSIP
140755208
Type
Equity
Class
COM NEW
Num filers
46
Total reported value, excl. options
$6.58M
Compare 2024 Q4 to
2025 Q4
2025 Q3
2025 Q2
2025 Q1
2024 Q3
Manager
Report Date
Value ($000)
Shares
Option Type